去年，Xtant Medical Holdings Inc表现最佳的业务板块Orthobiologics实现营收72.89M美元。United States的营收贡献最高，去年达到122.45M美元。最近一个季度，截至2026-06-30，Xtant Medical Holdings Inc表现最佳的业务板块Orthobiologics实现营收17.36M美元。United States的营收贡献最高，达到22.46M美元。

业务

营业收入

占比

年报

年报

单季报

Orthobiologics

Spinal implant

License revenue

Other revenue

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Orthobiologics

72.89M(54.43%)

66.42M(56.64%)

58.60M(64.19%)

47.14M(81.32%)

42.26M(76.47%)

39.31M(73.70%)

46.66M(72.14%)

48.98M(67.84%)

Spinal implant

42.31M(31.59%)

49.35M(42.08%)

32.70M(35.81%)

10.81M(18.66%)

12.89M(23.32%)

13.88M(26.02%)

17.87M(27.63%)

22.83M(31.62%)

License revenue

18.72M(13.98%)

1.50M(1.28%)

--(--)

Other revenue

--(--)

11.00K(0.02%)

117.00K(0.21%)

149.00K(0.28%)

147.00K(0.23%)

389.00K(0.54%)

地区

营业收入

占比

年报

年报

单季报

United States

Rest of World

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

122.45M(91.43%)

105.52M(89.98%)

85.86M(94.04%)

57.16M(98.61%)

54.57M(98.75%)

52.15M(97.77%)

62.38M(96.44%)

68.88M(95.40%)

79.74M(96.52%)

85.62M(95.13%)

56.75M(95.63%)

34.64M(98.05%)

32.49M(98.23%)

31.95M(96.87%)

29.57M(98.08%)

Rest of World

11.48M(8.57%)

11.75M(10.02%)

5.44M(5.96%)

807.00K(1.39%)

693.00K(1.25%)

1.19M(2.23%)

2.31M(3.56%)

3.32M(4.60%)

2.87M(3.48%)

4.38M(4.87%)

2.60M(4.37%)

688.24K(1.95%)

584.59K(1.77%)

1.03M(3.13%)

578.04K(1.92%)